Statistics

Total Visits

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of KRAS wild-type metastatic colorectal cancer: Final results of a phase II open-label clinical trial105

Select a period of time:

Number of views in the range

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of KRAS wild-type metastatic colorectal cancer: Final results of a phase II open-label clinical trial36

Views

Views
November 20253
December 20256
January 20266
February 20260
March 20264
April 20267
May 202610
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
France8
Argentina5
Mexico3
Brazil1
Chile1
Colombia1
Ecuador1
Finland1
Nigeria1
 

Top cities views

Views
San Jose6
Alejandro Korn1
Ankara1
Bogotá1
Corrientes1
Danville1
Dunkirk1
Helsinki1
Ibadan1
Montevideo1